Melinda Pruis

Melinda Pruis

Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.

Back to news

More news

Update on the GENAYA Project: DNA from 500 Young Cancer Patients Analyzed

Update on the GENAYA Project: DNA from 500 Young Cancer Patients Analyzed

29-07-2025

Should young people with cancer receive different treatment than older patients? We suspect they do, but there’s currently not enough …

GMS and Hartwig sign MOU to advance precision medicine for cancer patients 

GMS and Hartwig sign MOU to advance precision medicine for cancer patients 

01-06-2026

Genomic Medicine Sweden (GMS) and Hartwig Medical Foundation (Hartwig) today signed a Memorandum of Understanding (MoU). This MoU formalises a strategic partnership …

Catalog makes Hartwig Medical Database easily searchable 

Catalog makes Hartwig Medical Database easily searchable 

29-09-2023

Hartwig Medical Foundation maintains a catalog of the Hartwig Medical Database with whole-genome data on full tumor genomes: https://catalog.hartwigmedicalfoundation.nl. The …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl